During the past decade, Hudson Valley Urology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 12 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hudson Valley Urology" #1 sponsor was "Ferring Pharmaceuticals" with 5 trials, followed by "GP-Pharm" with 2 trials sponsored, "Medi-Tate Ltd." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Predictive Biosciences" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hudson Valley Urology" #1 collaborator was "ClinPhone, Inc." with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Dainippon Sumitomo Pharma America" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hudson Valley Urology" are "Prostate Cancer" (5 trials), "Nocturia" (2 trials), "Urinary Incontinence" (2 trials), "Benign Prostate Hyperplasia" (1 trials) and "Benign Prostatic Hyperplasia (BPH)" (1 trials). Many other conditions were trialed in "Hudson Valley Urology" in a lesser frequency.

Most popular intervention types in "Hudson Valley Urology" are "Drug" (20 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Degarelix" (3 trials), "Tanezumab" (2 trials), "leuprolide acetate" (2 trials) and "AQUAVAN® (fospropofol disodium) Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hudson Valley Urology" are 14 trials for "Male" genders, 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hudson Valley Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hudson Valley Urology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hudson Valley Urology, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".